Renal · Tuesdays
Potassium control: evidence in focus
A SAHPRA reagent recall, new potassium-control evidence and a phosphate-treatment study update, with practical implications for South African renal teams.
Listen to the full brief4:09
Sources
- SAHPRA — HumaMeter A1c reagent-kit recall (posted 13 October; notice dated 8 October 2026) (opens in a new tab)
- Nature Communications — sodium zirconium cyclosilicate and RAAS optimisation trial (14 October 2026) (opens in a new tab)
- R1 Therapeutics — AP306 phase 2b trial-in-progress announcement (15 October 2026) (opens in a new tab)